Xianzhang Bu

Xianzhang Bu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XQXu Qiu
Xu Qiu
YDYuhong Du
Yuhong Du
BLBin Lou
Bin Lou
YZYinglin Zuo
Yinglin Zuo
WSWeiyan Shao
Weiyan Shao
XBXianzhang Bu
Xianzhang Bu

21 June 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JZJianyong Zhu
Jianyong Zhu
RWRuimin Wang
Ruimin Wang
LLLanlan Lou
Lanlan Lou
WLWei Li
Wei Li
GTGuihua Tang
Guihua Tang
SYSheng Yin
Sheng Yin

1 December 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
HLHao Liu
Hao Liu
BZBin-Hua Zhou
Bin-Hua Zhou
XQXu Qiu
Xu Qiu
HWHong-Sheng Wang
Hong-Sheng Wang
FZFan Zhang
Fan Zhang
XBXianzhang Bu
Xianzhang Bu

2 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
XWXiaoquan Wang
Xiaoquan Wang
YWYouqiao Wang
Youqiao Wang
ACAnqi Cao
Anqi Cao
QLQinhong Luo
Qinhong Luo
DCDaoyuan Chen
Daoyuan Chen
JQJunmin Quan
Junmin Quan
Cyclic GMP-AMP synthase (cGAS) is an essential sensor of aberrant cytosolic DNA for initiating innate immunity upon invading pathogens and cellular stress, which is considered as a potential drug target for autoimmune and autoinflammatory diseases. Here, we report the discovery of a class of cyclopeptide inhibitors of cGAS identified by an in vitro screening assay from a focused library of cyclic peptides. These cyclopeptides specifically bind to the DNA binding site of cGAS and block the binding of dsDNA with cGAS, subsequently inhibit dsDNA-induced liquid phase condensation and activation of cGAS. The specificity and potency of one optimal lead XQ2B were characterized in cellular assays. Concordantly, XQ2B inhibited herpes simplex virus-1 (HSV-1)-induced antiviral immune responses and enhanced HSV-1 infection in vitro and in vivo. Furthermore, XQ2B significantly suppressed the elevated levels of type I interferon and proinflammatory cytokines in primary macrophages from Trex1-/- mice and systemic inflammation in Trex1-/- mice. XQ2B represents the specific cGAS inhibitor targeting protein-DNA interaction and phase separation and serves as a scaffold for the development of therapies in the treatment of cGAS-dependent inflammatory diseases.

25 July 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CZCuige Zhu
Cuige Zhu
YZYinglin Zuo
Yinglin Zuo
RWRuimin Wang
Ruimin Wang
BLBaoxia Liang
Baoxia Liang
XYXin Yue
Xin Yue
XBXianzhang Bu
Xianzhang Bu

8 May 2014 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LHLei Huang
Lei Huang
YCYu Chen
Yu Chen
BLBaoxia Liang
Baoxia Liang
BXBengang Xing
Bengang Xing
GWGesi Wen
Gesi Wen
XBXianzhang Bu
Xianzhang Bu
A simple and novel furanyl acryl conjugated coumarin fluorophore was designed as an effective thioredoxin reductase (TrxR)-responding fluorescent probe by an activity-guided approach. Basically, the α,β-unsaturated ketone moiety in the probe structure could quench the fluorescence of the coumarin, but upon the covalent modification of TrxR, a significant fluorescence could be generated, which has been confirmed to be obviously selective over Trx, GSH, Cys and DTT.